BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6618141)

  • 1. [Body's oxygen supply after total blood substitution with organofluoric emulsions].
    Iarochkin VS; Koziner VB; Kolonina IR; Afonin NI
    Gematol Transfuziol; 1983 Jul; 28(7):47-51. PubMed ID: 6618141
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxygen delivery augmentation by low-dose perfluorochemical emulsion during profound normovolemic hemodilution.
    Keipert PE; Faithfull NS; Bradley JD; Hazard DY; Hogan J; Levisetti MS; Peters RM
    Adv Exp Med Biol; 1994; 345():197-204. PubMed ID: 8079708
    [No Abstract]   [Full Text] [Related]  

  • 3. [Human infusion of perfluorocarbons as blood substitutes].
    Ivanov KP
    Gematol Transfuziol; 1984 Jul; 29(7):40-7. PubMed ID: 6381221
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indices of oxygen supply to the bodies of rats following blood replacement by a perfluorodecalin emulsion].
    Chaplygina ZA; Kuznetsova IN; Domracheva VS; Gokhman NSh; Maksimov BN
    Biull Eksp Biol Med; 1980 Nov; 90(11):546-8. PubMed ID: 6778535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical potential of intravenously administered perfluorocarbons.
    Habler O; Kleen M; Messmer K
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fluosol-DA in extracorporeal circulation - an experimental study (author's transl)].
    Ozono H; Taira A; Toyohira H; Higashi T; Yamashita M; Shimokawa S; Umebayashi Y; Saigenji H; Hamada Y; Arikawa K; Akita H
    Kyobu Geka; 1981 Oct; 34(10):776-80. PubMed ID: 7311221
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental studies on the possible combined chemotherapy to neoplasms with Fluosol-DA infusion.
    Ohyanagi H; Nishijima M; Usami M; Nishimatsu S; Matsui E; Saitoh Y
    Prog Clin Biol Res; 1983; 122():315-20. PubMed ID: 6576383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [State of circulation and the body's oxygen supply following total blood replacement with perfluorotributylamine emulsion].
    Fedorov NA; Iarochkin VS; Kolonina IR; Afonin NI
    Biull Eksp Biol Med; 1980 May; 89(5):525-7. PubMed ID: 6772252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of perfluoroorganic emulsions on hematological indicators in laboratory animals].
    Sedova LA; Piatovskaia NN
    Gematol Transfuziol; 1985 Feb; 30(2):35-7. PubMed ID: 3979792
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intravenous perfluorocarbons. Artificial oxygen carriers and their medical applications].
    Frietsch T; Lenz C; Waschke KF
    Dtsch Med Wochenschr; 2000 Apr; 125(15):465-72. PubMed ID: 10800445
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluorocarbons as possible oxygen-carrying blood substitutes].
    Afonin NI; Doronina NN
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):41-5. PubMed ID: 7220520
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gas exchange and blood circulation status in dogs following replacement of acute blood loss by perfluoro compound emulsions].
    Akhsianov UU; Afonin NI; Troitskiĭ VB; Sukiasian GV; Karpov AP
    Biull Eksp Biol Med; 1983 Sep; 96(9):21-3. PubMed ID: 6616046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oxygen supply of the body during the administration organofluorine emulsions (a pathophysiological analysis)].
    Iarochkin VS; Koziner VB
    Patol Fiziol Eksp Ter; 1988; (3):81-6. PubMed ID: 3050820
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
    Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnetometric measurements of macrophage activity in the liver after administration of different perfluorochemicals.
    Koester MB; Lutz J
    Adv Exp Med Biol; 1994; 345():215-20. PubMed ID: 8079710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipid vesiculated fluorocarbons--promising trend in blood substitutes.
    Gross U; Rüdiger S; Reichelt H; Draffehn J
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):831-3. PubMed ID: 1391517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perflubron emulsion and 100% oxygen breathing on local tissue PO2 in brain cortex of unanaesthetized rabbits.
    van Rossem K; Vermariën H; Faithfull NS; Wouters L; Decuyper K
    Adv Exp Med Biol; 1997; 411():403-9. PubMed ID: 9269456
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy.
    Riess JG; Dalfors JL; Hanna GK; Klein DH; Krafft MP; Pelura TJ; Schutt EG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):839-42. PubMed ID: 1391519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of fetal exchange transfusion with a red blood cell substitute.
    Ambrose A; Cefalo RC; Bowes WA
    Am J Obstet Gynecol; 1986 Mar; 154(3):667-74. PubMed ID: 3082209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
    Cohn CS; Cushing MM
    Crit Care Clin; 2009 Apr; 25(2):399-414, Table of Contents. PubMed ID: 19341916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.